Resiliency Technologies and EMRAY Partner to Bring Evidence-Based Therapeutics to Clinical Workflows

Charlotte, North Carolina Nov 20, 2025 (Issuewire.com) Resiliency Technologies Inc., a provider of evidence-based Sharpen digital therapeutic (Sharpen DTX) mental health treatment interventions operating across the United States, today celebrates its partnership with EMRAY, an integration platform for health innovators that enables seamless embedding into healthcare provider workflows through electronic health record (EHR) pre-integration.

Through this collaboration, Resiliency Technologies Sharpen DTX solution is live within healthcare systems utilizing both Epic and Charm Health EHRs, expanding clinicians access to evidence-based treatment interventions and paving the way for broader adoption across various clinical settings.

Upon achieving clinical validation through years of research and collaboration with hundreds of inter-disciplinary researchers in neuroscience, psychology and resilience, Resiliency Technologies developed a range of evidence-based interventions for diverse conditions, united under the digital mental health solution Sharpen DTX. The companys next milestone was to bring this digital therapeutic solution into everyday clinical practice to improve collaborative care best practices. Achieving this required integration into existing provider workflows, specifically, a clinician-facing interface designed to extend rather than disrupt EHR-based routines, and seamless connectivity with patient data within the EHR.

To accelerate clinical adoption, Resiliency Technologies partnered with EMRAY, a platform purpose-built for digital health innovators with a pre-integrated provider-facing portal and EHR data connectivity capabilities.

Adding Resiliency Technologies as an integrated partner on the EMRAY platform allowed rapid traction within hospitals utilizing Epic as its EHR. Separately, Sharpen DTX is also live in Charm Health EHR. In both cases, clinicians can utilize the Sharpen DTX product seamlessly, without additional logins and windows, through single sign-on integration. With very positive early data in hand, Resiliency Technologies is expanding into additional clinic networks. This milestone demonstrates how frictionless EHR integration accelerates the adoption of innovative digital health solutions.

Clinically proven care only scales when providers can access it without changing how they work. Sharpen DTX eliminates friction at crucial points in the collaborative care ecosystem: during primary care visits, while patients are on waitlists for psychiatric care, and for use in between clinical sessions. We are grateful to EMRAY for helping us accelerate impact in all of these areas, said Robyn Hussa Farrell, CEO and Co-Founder of Resiliency Technologies.

Resiliency Technologies is exactly the kind of company EMRAY was built for, said Olga Ryzhikova, CTO of EMRAY. We make it simple for digital health innovators to implement with healthcare systems faster.

About Sharpen DTX. Sharpen DTX is a digital mental health solution by Resiliency Technologies Inc. that delivers scientifically validated digital therapeutic treatment interventions designed to support measurable mental health improvements in children, adolescents and adults.

About EMRAY. EMRAY is a platform that accelerates clinical adoption of early healthcare innovations through quick deployment of EHR-integrated provider-facing portals.